Drug Shortage Report for CABLIVI
| Report ID | 225859 |
| Drug Identification Number | 02496194 |
| Brand name | CABLIVI |
| Common or Proper name | caplacizumab |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CAPLACIZUMAB |
| Strength(s) | 11MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1 vial/box |
| ATC code | B01AX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-05-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-02 |
| Company comments | Business reasons |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-05-02 | English | Compare |
| v2 | 2024-04-22 | French | Compare |
| v1 | 2024-04-22 | English | Compare |
Showing 1 to 3 of 3